Marc Odrich - 09 Jan 2025 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Chief Medical Officer
Signature
/s/ Daniel R. Chevallard, as Attorney-in-Fact
Issuer symbol
LENZ
Transactions as of
09 Jan 2025
Net transactions value
$0
Form type
4
Filing time
13 Jan 2025, 17:24:55 UTC
Previous filing
25 Mar 2024
Next filing
06 Jan 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LENZ Stock Option (right to buy) Award $0 +80,100 $0.000000 80,100 09 Jan 2025 Common Stock 80,100 $26.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean January 9, 2025.

Remarks:

Exhibit 24 - Power of Attorney